Sale!

Qsymia 11.25mg/69mg (Phentermine and Topiramate) – 30 Capsules per Bottle

$170.00 $145.00

Qsymia (Phentermine and Topiramate) 11.25mg/69mg is a combination oral product comprised of immediate-release phentermine hydrochloride (expressed as the weight of the free base) and extended-release topiramate.

Name: Qsymia

Dosage: 11.25mg/69mg

Packing: 30 Capsules per bottle

Product form: Capsule

Description

Qsymia 11.25mg/69mg is a combination oral product comprised of immediate-release phentermine hydrochloride (expressed as the weight of the free base) and extended-release topiramate.

Qsymia 11.25mg/69mg contains phentermine hydrochloride, a sympathomimetic amine anorectic, and topiramate, a sulfamate-substituted monosaccharide related to fructose antiepileptic drug.

Qsymia Side Effects

Patients who get pregnant while taking Qsymia have a “small yet increased risk of cleft lip and/or palate,” according to Craig Primack, MD, FAAP. Primack, the medical director of Scottsdale Weight Loss Center, explained the FDA recommendation that women of childbearing age take a monthly pregnancy test while on Qsymia (Phentermine and Topiramate) 11.25mg/69mg. He says that, since the lip and cleft form at weeks 6-8 of pregnancy, women need to know immediately if they become pregnant. This allows them to stop taking the drug before a birth defect occurs.

Other possible side effects of the weight loss medication include increased heart rate, depression, mood problems, trouble sleeping, eye problems, and concentration or speech difficulties. The drug maker also recommends that patients receive regular heart-rate monitoring, and does not recommend the use of Qsymia in patients with recent or unstable cardiac issues or cerebrovascular disease since its use in these patients has not been studied. If you decide to take Qsymia, your pharmacist or physician will provide you with complete drug information including side effects.

Indications

Qsymia (Phentermine and Topiramate) 11.25mg/69mg is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of

30 kg/m2 or greater (obese), or
27 kg/m2 or greater (overweight) in the presence of at least one weight related comorbidity such as hypertension, type 2 diabetes mellitus, or dyslipidemia

Limitations Of Use

The effect of Qsymia 11.25mg/69mg on cardiovascular morbidity and mortality has not been established.
The safety and effectiveness of this drug in combination with other products intended for weight loss, including prescription and over-the-counter drugs and herbal preparations have not been established. Visit our store for more products.

Reviews

There are no reviews yet.

Be the first to review “Qsymia 11.25mg/69mg (Phentermine and Topiramate) – 30 Capsules per Bottle”

Your email address will not be published. Required fields are marked *

Select your currency
USD United States (US) dollar
EUR Euro
error: Content is protected !!
X